Opportunity Information: Apply for CDC RFA GH16 1652
Apply for CDC RFA GH16 1652
- The HHS-CDC-CGH in the health sector is offering a public funding opportunity titled "Comprehensive Community-Based HIV Prevention, Linkage, and Retention Services for Key Populations and Adolescent Girls and Young Women in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Dec 08, 2015 and posted on Dec 08, 2015.
- Applicants must submit their applications by Feb 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $630,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Comprehensive Community-Based HIV Prevention, Linkage, and Retention Services for Key Populations and Adolescent Girls and Young Women in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a CDC-funded cooperative agreement designed to strengthen HIV prevention and treatment outcomes in Tanzania by concentrating on groups with heightened vulnerability to HIV. It is issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), through CDC's Center for Global Health, and it sits within the CFDA program area 93.067. The funding mechanism is a cooperative agreement, which usually means the CDC anticipates an active role in guiding or collaborating on program design, implementation, monitoring, and evaluation rather than acting solely as a passive funder.
At the center of the program is a practical, service-delivery focus: finding and engaging people most at risk of HIV acquisition and transmission, specifically key populations (KP) and adolescent girls and young women (AGYW), and then connecting them to a set of evidence-based prevention and clinical services. In PEPFAR and public health usage, "key populations" typically refers to communities that experience elevated HIV risk and face persistent barriers to care due to stigma, discrimination, legal concerns, or limited access to tailored services. "Adolescent girls and young women" are prioritized because they often face a combination of biological vulnerability, gender inequality, economic dependence, and social pressures that can increase exposure risk and reduce negotiating power for safer sex, which in turn can undermine prevention and consistent engagement in services.
The stated purpose is twofold: first, to identify individuals within these priority groups who are most at risk, and second, to deliver appropriate services that match their needs and circumstances. The FOA emphasizes evidence-based interventions, indicating that applicants are expected to rely on approaches with demonstrated effectiveness, such as targeted HIV testing strategies, prevention counseling and risk-reduction services, condom promotion and distribution, and strong referral and navigation systems to move people efficiently into clinical care when needed. In the PEPFAR context, this kind of community-based programming is often intended to complement facility-based services by reaching people where they live, socialize, or work, and by reducing the friction points that commonly cause individuals to drop out between testing, diagnosis, and treatment initiation.
The program's goals are explicitly tied to measurable HIV outcomes across the prevention-to-treatment continuum. It aims to improve case detection, meaning the ability to find people living with HIV who are undiagnosed and to diagnose them earlier. It also aims to improve linkage to clinical services, referring to the speed and completeness with which a person who tests positive is connected to HIV care and initiated or re-initiated on antiretroviral therapy (ART) when appropriate. Beyond linkage, the FOA highlights retention in clinical services, acknowledging that staying in care over time is essential for long-term health and for reducing onward transmission. Adherence to ART is called out separately, which reflects how critical consistent medication-taking behavior is for achieving viral suppression. Viral suppression, in turn, is a primary endpoint because it is associated with dramatically improved health outcomes and a substantial reduction in the risk of sexual transmission.
On the prevention side, the FOA lists condom use as a desired improvement area, reinforcing the expectation that funded activities will not only supply condoms but also increase consistent and correct use through education, counseling, and addressing barriers such as stigma, partner dynamics, and access issues. The FOA also includes access to MAT, or medication-assisted treatment, which is commonly used in the context of opioid use disorder and is relevant to HIV prevention and care because substance use can increase risk behaviors and create major obstacles to consistent engagement in treatment. By including MAT, the opportunity signals that the program is expected to address HIV risk and treatment outcomes in a more integrated way, particularly for populations where substance use contributes to risk or destabilizes retention in care.
In terms of basic award structure and scale, the opportunity is listed under funding opportunity number CDC RFA GH16-1652. It was posted on December 8, 2015, with the application closing date of February 8, 2016. The award ceiling is $630,000, and the CDC anticipated making one award, indicating a single recipient would likely be responsible for implementing the program, potentially through a network of sub-awards, implementing partners, community organizations, or clinical partners. The opportunity category is discretionary, meaning it is a competitive grant rather than an entitlement or formula-based award. Eligibility is described broadly as "Others," with additional eligibility clarification referenced in the full notice, which typically implies the CDC may allow applications from a range of entities such as non-governmental organizations, non-profits, academic institutions, and possibly other types of organizations able to demonstrate capacity to implement community-based HIV programming in Tanzania.
Overall, the opportunity is framed around improving performance along the HIV service cascade for populations that often face the greatest barriers to prevention and sustained care. It prioritizes practical outcomes that are widely used in PEPFAR program management: more people diagnosed, faster and stronger linkage to care, fewer people falling out of services, higher ART adherence, higher viral suppression, increased condom use, and better access to medication-assisted treatment where relevant. The cooperative agreement format suggests the CDC intended to remain engaged in shaping the program's technical approach and ensuring that implementation aligns with PEPFAR goals and evidence-based public health practice in Tanzania.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Comprehensive Community-Based HIV Prevention, Linkage, and Retention Services for Key Populations and Adolescent Girls and Young Women in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)."
Which agency is offering this funding?
This is a CDC-funded cooperative agreement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), through CDC's Center for Global Health.
What is the funding opportunity number?
The funding opportunity number is CDC RFA GH16-1652.
What type of award is this?
This opportunity uses a cooperative agreement mechanism. That generally means CDC expects to have an active role in the project, such as collaborating on program design, implementation, monitoring, and evaluation, rather than only providing funds with minimal involvement.
What CFDA program area is associated with this opportunity?
This opportunity sits within CFDA program area 93.067.
What is the overall purpose of the program?
The stated purpose is twofold: (1) identify individuals in priority groups who are most at risk of HIV acquisition and transmission, and (2) deliver appropriate, evidence-based prevention and clinical services that match their needs and circumstances.
Where will the program be implemented?
The opportunity is focused on the United Republic of Tanzania.
Which populations are prioritized by this FOA?
The FOA prioritizes key populations (KP) and adolescent girls and young women (AGYW), described as groups with heightened vulnerability to HIV and persistent barriers to accessing prevention and care services.
How does the FOA describe "key populations" (KP) in this context?
In PEPFAR and public health usage, "key populations" typically refers to communities that experience elevated HIV risk and face persistent barriers to care due to factors like stigma, discrimination, legal concerns, or limited access to tailored services.
Why are adolescent girls and young women (AGYW) specifically emphasized?
AGYW are prioritized because they may face combined risks such as biological vulnerability, gender inequality, economic dependence, and social pressures that can increase exposure to HIV and make it harder to consistently use prevention measures or stay engaged in services.
Is this opportunity focused on service delivery or on research?
Based on the description provided, the program is centered on practical, community-based service delivery. It emphasizes finding and engaging people at risk, then connecting them to evidence-based prevention and clinical services, including effective referral and navigation into care.
What does "community-based" programming mean here?
In the PEPFAR context described, community-based programming is intended to complement facility-based services by reaching people where they live, socialize, or work, and by reducing common drop-off points between testing, diagnosis, and treatment initiation.
What kinds of interventions does the FOA expect applicants to use?
The FOA emphasizes evidence-based interventions. Examples mentioned include targeted HIV testing strategies, prevention counseling and risk-reduction services, condom promotion and distribution, and strong referral and navigation systems to efficiently connect people to clinical care when needed.
What outcomes is the program trying to improve?
The goals are tied to measurable HIV outcomes across the prevention-to-treatment continuum, including improved case detection, stronger and faster linkage to clinical services, better retention in clinical services, improved ART adherence, and higher viral suppression.
What does "case detection" refer to in this FOA?
Case detection refers to finding people living with HIV who are undiagnosed and diagnosing them earlier.
What does "linkage to clinical services" mean in this opportunity?
Linkage refers to the speed and completeness with which a person who tests positive is connected to HIV care and initiated or re-initiated on antiretroviral therapy (ART) when appropriate.
Why does the FOA emphasize retention in clinical services?
Retention is highlighted because staying in care over time is essential for long-term health outcomes and for reducing onward transmission.
Why is ART adherence called out separately from retention?
ART adherence is identified as critical because consistent medication-taking behavior is a major driver of achieving viral suppression, which is a key endpoint for both individual health and reducing sexual transmission risk.
What is viral suppression and why is it important in this program?
Viral suppression is a primary endpoint because it is associated with dramatically improved health outcomes and a substantial reduction in the risk of sexual transmission.
What prevention-related outcomes are emphasized?
On the prevention side, the FOA specifically highlights improving condom use and strengthening access to MAT (medication-assisted treatment) where relevant.
Does the FOA include condom distribution?
Yes. The description indicates that condom promotion and distribution are part of the expected evidence-based prevention package, alongside efforts to increase consistent and correct condom use through education and counseling and by addressing barriers such as stigma, partner dynamics, and access issues.
What is MAT and why is it included in an HIV-focused FOA?
MAT (medication-assisted treatment) is commonly used in the context of opioid use disorder. It is relevant to HIV prevention and care because substance use can increase HIV risk behaviors and create obstacles to consistent engagement in treatment. The FOA's inclusion of MAT signals an expectation for more integrated approaches for populations where substance use affects risk and retention.
How much funding is available under this opportunity?
The award ceiling listed is $630,000.
How many awards did CDC anticipate making?
CDC anticipated making one award.
What does it mean that CDC anticipated one award?
It suggests a single recipient would likely be responsible for implementing the overall program, potentially working through sub-awards, implementing partners, community organizations, or clinical partners.
Is this a discretionary or formula/entitlement program?
The opportunity category is discretionary, meaning it is a competitive grant rather than an entitlement or formula-based award.
Who is eligible to apply?
Eligibility is described broadly as "Others," with additional eligibility clarification referenced in the full notice. This typically implies CDC may accept applications from a range of entities (for example, non-governmental organizations, non-profits, academic institutions, and potentially other organizations) that can demonstrate capacity to implement community-based HIV programming in Tanzania.
What are the key dates for this funding opportunity?
The opportunity was posted on December 8, 2015, and the application closing date was February 8, 2016.
What role does PEPFAR play in this opportunity?
The FOA is explicitly framed under PEPFAR and aligns with PEPFAR program management priorities and outcomes, such as diagnosing more people, strengthening linkage and retention, improving ART adherence and viral suppression, increasing condom use, and improving access to MAT where relevant.
How does the cooperative agreement structure affect implementation expectations?
Because this is a cooperative agreement, CDC is expected to be engaged in shaping the program's technical approach and in ensuring implementation aligns with PEPFAR goals and evidence-based public health practice in Tanzania, including monitoring and evaluation.
Browse more business programs for Women in Business
Browse more opportunities from the same agency: HHS-CDC-CGH
Browse more opportunities from the same category: Health
Next opportunity: NHLBI Early Investigator Award (EIA) (R35)
Previous opportunity: Organic Agriculture Research and Extension Initiative
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH16 1652
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH16 1652) also looked into and applied for these:
| Funding Opportunity |
|---|
| NHLBI Early Investigator Award (EIA) (R35) Apply for RFA HL 16 025 Funding Number: RFA HL 16 025 Agency: HHS-NIH11 Category: Health Funding Amount: $600,000 |
| Supporting Implementation of HIV and TB Services for Epidemic Control in the Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1632 Funding Number: CDC RFA GH16 1632 Agency: HHS-CDC-CGH Category: Health Funding Amount: $80,000,000 |
| Enhancing the Government of India’s Capacity to Scale Up and Improve Comprehensive HIV Service Package Quality for People Who Inject Drugs under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 154202CONT16 Funding Number: CDC RFA GH15 154202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Flex Rural Veterans Health Access Program Apply for HRSA 16 015 Funding Number: HRSA 16 015 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Targeted Capacity Expansion-Peer-to-Peer (Short Title: TCE-PTP) Apply for TI 16 008 Funding Number: TI 16 008 Agency: HHS-SAMHS Category: Health Funding Amount: $250,000 |
| Implementing Comprehensive Community Based HIV/AIDS Prevention, Care and Treatment Services in Priority Areas in the Republic of Zambia under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1668 Funding Number: CDC RFA GH16 1668 Agency: HHS-CDC-CGH Category: Health Funding Amount: $2,500,000 |
| Cooperative Agreements for Adolescent and Transitional Aged Youth Treatment Implementation [Youth Treatment – Implementation (Short Title –YT-I)] Apply for TI 16 006 Funding Number: TI 16 006 Agency: HHS-SAMHS Category: Health Funding Amount: $800,000 |
| Scholarships for Disadvantaged Students (SDS) Apply for HRSA 16 069 Funding Number: HRSA 16 069 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Early HIV Treatment to Optimize Patient Health and HIV Prevention Apply for RFA PS 16 006 Funding Number: RFA PS 16 006 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $495,000 |
| Academic Units for Primary Care Training and Enhancement Apply for HRSA 16 041 Funding Number: HRSA 16 041 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp) Apply for PA 16 013 Funding Number: PA 16 013 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Western Region and Turkana County of the Republic of Kenya under the President’s Emergency Plan for AIDS R Apply for CDC RFA GH16 1619 Funding Number: CDC RFA GH16 1619 Agency: HHS-CDC-CGH Category: Health Funding Amount: $103,000,000 |
| NHLBI Clinical Trial Pilot Studies (R34) Apply for PAR 16 037 Funding Number: PAR 16 037 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Pulmonary and Cardiovascular Consequences of Inhaled Nicotine (R01) Apply for RFA HL 17 008 Funding Number: RFA HL 17 008 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Evaluating the Impact of Non-pharmaceutical Measures on the Incidence of Influenza-like Illness (ILI) among K-12 Students in the United States Apply for RFA CK 16 005 Funding Number: RFA CK 16 005 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| Novel Genomic Technology Development Direct to Phase II SBIR (R44) Apply for PAR 16 017 Funding Number: PAR 16 017 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| High-End Instrumentation (HEI) Grant Program (S10) Apply for PAR 16 053 Funding Number: PAR 16 053 Agency: HHS-NIH11 Category: Health Funding Amount: $2,000,000 |
| Research on the Epidemiology, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in Southeast Asia and the Western Pacific Apply for RFA IP 16 001 Funding Number: RFA IP 16 001 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $3,000,000 |
| Supporting the National Blood Transfusion Service (NBTS) in the implementation and strengthening of Blood Safety activities in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10260501SUPP16 Funding Number: CDC RFA PS10 10260501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $927,809 |
| National Child Traumatic Stress Initiative – Category III Community Treatment and Services (CTS) Centers Apply for SM 16 005 Funding Number: SM 16 005 Agency: HHS-SAMHS Category: Health Funding Amount: $400,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH16 1652", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.